The NBOMe series: A novel, dangerous group of hallucinogenic drugs

Journal of Studies on Alcohol and Drugs

Volumn 74, Issue 6, 2013, Pages 977-978

  Ninnemann, Andrew ^a   Stuart, Gregory L ^b,c  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENETHYLAMINE DERIVATIVE; PSYCHEDELIC AGENT; STREET DRUG;

ADDICTION; CHEMISTRY; HUMAN; LETTER;

HALLUCINOGENS; HUMANS; PHENETHYLAMINES; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84888345452     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2013.74.977     Document Type: Letter

References (17)

1. Caldicott, D. G. E., Bright, S. J., & Barratt, M. J. (2013). NBOMe-a very different kettle of fi sh. [Letter to the editor]. Medical Journal of Australia, 199, 322-323.
2. Erowid. (2012, April 28). NBOMe series effects. Retrieved from http://www. erowid. org/chemicals/nbome/nbome_effects. shtml.
3. Erowid. (2013a, September 9). 25I-NBOMe (2C-I-NBOMe) fatalities/deaths. Retrieved from http://www. erowid. org/chemicals/2ci_nbome/2ci_nbome_death. shtml.
4. Erowid. (2013b, September 7). Other or unknown NBOMe compound fatalities/deaths. Retrieved from http://www. erowid. org/chemicals/nbome/nbome_death. shtml.
5. Erowid. (2013c, July 19). 25C-NBOMe (2C-C-NBOMe) fatalities/deaths. Retrieved from http://www. erowid. org/chemicals/2cc_nbome/2cc_nbome_death. shtml.
6. Erowid. (2013d, July 30). NBOMe series legal status. Retrieved from http://www. erowid. org/chemicals/nbome/nbome_law. shtml.
7. Erowid, E., & Erowid, F. (2013, September 12). LSD fi eld tests differentiate LSD from 25I-NBOMe. Retrieved from http://www. erowid. org/chemicals/lsd/lsd_testing3. shtml European Union: Nightlife Empowerment & Well-being Implementation.
8. Project. (2013). 2nd TEDI trend report. Retrieved from http://www. tediproject. org/uploads/trend_reports_fi le_1359936258. pdf.
9. Global Drug Survey. (2013). 2013 Global Drug Survey News. Retrieved from http://globaldrugsurvey. com/run-my-survey/global-drug-survey-2013.
10. Hill, S. L., Doris, T., Gurung, S., Katebe, S., Lomas, A., Dunn, M.,. Thomas, S. H. L. (2013). Severe clinical toxicity associated with analytically confi rmed recreational use of 25I-NBOMe: Case series. Clinical Toxicology, 51, 487-492.
11. Jerry, J., Collins, G., & Streem, D. (2012). Synthetic legal intoxicating drugs: The emerging 'incense' and 'bath salt' phenomenon. Cleveland Clinic Journal of Medicine, 79, 258-264.
12. Mixmag. (2013, April 18). Mixmag's Global Drug Survey: The results. Retrieved from http://www. mixmag. net/words/features/mixmags-global-drug-survey-the-results.
13. Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The pharmacology of lysergic acid diethylamide: A review. CNS Neuroscience & Therapeutics, 14, 295-314.
14. Poklis, J. L., Charles, J., Wolf, C. E., & Poklis, A. (2013). High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum. Biomedical Chromatography. Advance online publication. Retrieved from http://onlinelibrary. wiley. com/doi/10. 1002/bmc. 2999/pdf.
15. Ralston, N., & Davies, L. (2013, June 6). Teen jumps to his death after $1. 50 drug hit. The Sydney Morning Herald. Retrieved from http://www. smh. com. au/nsw/teen-jumps-to-his-death-after-150-drug-hit-20130606-2nrpe. html.
16. Rega, P. P., Corden, T. E., Brenner, S., Darling, R. G., Dribben, W. H., Hall, A. H.,. Wood, A. (2013, September 9). LSD toxicity treatment & management. Medscape. Retrieved from http://emedicine. medscape. com/article/1011615-treatment.
17. Zuba, D., Sekuła, K., & Buczek, A. (2013). 25C-NBOMe-New potent hallucinogenic substance identifi ed on the drug market. Forensic Science International, 227, 7-14.